The results suggested that infection, usage of rhBNP and high LDH were risk factors that increased the hospital expenses for patients with CHF, while the use of Sacubitril/Valsartan and high prealbumin were protective factors for reducing hospital expenses of for patients with CHF (Table 7). The gene discussed is TTR; the disease is infection.